ConvaTec saga continues to hobble Scapa

The adhesive products specialist experienced hits to trading profits in both of its divisions

November 19, 2019

Scapa (SCPA) was pushed into a first-half loss by medical technology group ConvaTec’s (CTEC) decision to exit a supply deal early, over which Scapa is pursuing $83m (£64m) in damages.

IC TIP: Sell at 232p

This is subscriber only content

Start your trial to keep reading

PRINT AND DIGITAL trial

Get 12 weeks for £12

Essential access to the website and app
Magazine delivered every week
Investment ideas, tools and analysis

Have an account? Sign in